ATPase
信号通路图
研究领域
- 抑制剂选择性比较
- 溶解性比较
| 目录号 | 产品目录 | 溶解度(25°C) | ||
|---|---|---|---|---|
| 水 | DMSO | 酒精 | ||
| S1478 | Oligomycin A | <1 mg/mL | 10 mg/mL | <1 mg/mL |
| S7046 | Brefeldin A | <1 mg/mL | 4 mg/mL | <1 mg/mL |
| S7099 | (-)-Blebbistatin | <1 mg/mL | 58 mg/mL | <1 mg/mL |
| S2000 | Sodium orthovanadate | 36 mg/mL | <1 mg/mL | <1 mg/mL |
| S5454 | Saikosaponin D | <1 mg/mL | 100 mg/mL | <1 mg/mL |
| S2528 | Ciclopirox | <1 mg/mL | 42 mg/mL | 42 mg/mL |
| S3019 | Ciclopirox ethanolamine | <1 mg/mL | 6 mg/mL | 30 mg/mL |
| S2233 | Esomeprazole sodium | 73 mg/mL | 73 mg/mL | 73 mg/mL |
| S7266 | Golgicide A | <1 mg/mL | 57 mg/mL | 4 mg/mL |
| S2222 | PF-3716556 | <1 mg/mL | 79 mg/mL | 79 mg/mL |
| S7460 | BTB06584 | <1 mg/mL | 84 mg/mL | <1 mg/mL |
| S3699 | 2,3-Butanedione-2-monoxime | 20 mg/mL | 20 mg/mL | 20 mg/mL |
| S8101 | CB-5083 | <1 mg/mL | 82 mg/mL | 13 mg/mL |
| S3628 | BHQ | <1 mg/mL | 10 mg/mL | 40 mg/mL |
| S8276 | FCCP | <1 mg/mL | 50 mg/mL | 50 mg/mL |
| S2623 | Omecamtiv mecarbil (CK-1827452) | <1 mg/mL | 80 mg/mL | 6 mg/mL |
- ATPase抑制剂（17）
- 新ATPase产品
| 产品目录 | 产品描述 | 文献引用 | 实验数据 |
|---|---|---|---|
| S1478New |
Oligomycin AOligomycin A是一种ATP synthase抑制剂，作用于线粒体膜的耦合过程，抑制氧化磷酸化和所有ATP依赖性反应。 |
(F) Detection of expression of SDHA and TOMM20 by immunoblotting in wild-type and Atg7-/- K562 cells with indicated drugs. The expression levels were quantified with number indicated. (G) Quantification analysis of mitochondrial mass in wild-type and Atg7-/- K562 cells when cultured with oligomycin(100 ng/ml), antimycin A(50 μM) and Baf-A1(10 nM).
|
|
| S7046 |
Brefeldin ABrefeldin A 作用于HCT 116细胞，抑制内酯抗生素和ATPase，作用于protein transport（蛋白转运），IC50为0.2 μM，诱导癌细胞分化和凋亡。 它还能提高同源重组修复效率，是CRISPR-mediated HDR的增强剂。 |
Immunofluorescence staining of LC3 protein expression of U2OS cells treated with DMSO (negative control), Rap (positive control, 500 nM), Tha (1 μM), Tun (2 μg/mL), BFA (10 μg/mL), and DTT (4 mM) for 8 h. Immunoblot of ER-phagy-related proteins of U2OS cells treated with four ER stress inducers.
|
|
| S7099 |
(-)-Blebbistatin(-)-Blebbistatin是一种细胞渗透性抑制剂，作用于非肌球蛋白IIATPase，无细胞试验中IC50为~2 μM，不抑制肌球蛋白轻链激酶，抑制卵裂沟的缢缩，不干扰有丝分裂或收缩环的组装。 |
(C) MyoIIA inhibition by blebbistatin treatment in vivo impairs leukemia cell extravasation into the brain. One hour before B-ALL cell transfer, C57BL/6 CD45.1+ recipient mice were treated with vehicle or blebbistatin (2.5 mg/kg). Twenty-four hours after B-ALL cell transfer, the recipient mice were intravenously injected with CD19-APC antibodies and then euthanized 4 min later.
|
|
| S2000 |
Sodium orthovanadateSodium orthovanadate是一种碱性磷酸酶和(Na，K)-ATPase抑制剂，IC50为10 μM。 |
||
| S5554New |
Lanatoside CLanatoside C, a cardiac glycoside which belongs to a class of compounds derived from plants called foxglove, possesses the ability to inhibit the interchange of Na+ and K+ across cell membrane and is widely used to treat anti-arrhythmias and heart failure. |
||
| S5454New |
Saikosaponin DSaikosaponin D, a calcium mobilizing agent (SERCA inhibitor), is a type of Saponin derivative, which is a component extracted from Bupleurum falactum. Saikosaponin D has anti-cancer activities. |
||
| S2528 |
CiclopiroxCiclopirox 是一种合成的抗真菌药物。 |
||
| S3019 |
Ciclopirox ethanolamineCiclopirox ethanolamine作为一种铁离子螯合剂，具有广谱抗真菌作用。 |
||
| S2233 |
Esomeprazole sodiumEsomeprazole Sodium 是Esomeprazole的一种钠盐，是有效的质子泵抑制剂，IC50为0.076 mg/kg。 |
||
| S7266 |
Golgicide AGolgicide A是一种有效的，快速可逆的GBF1抑制剂。 |
CSFV multiplication was inhibited by GCA. (A) The safe concentration of GCA was tested using the MTT assay. The operations and calculations were the same as those used for BFA. (B) Cellular CSFV RNA with or without 400 nM GCA were examined using real-time PCR. (C) The titers of CSFV with or without GCA were tested by IFA. (D) CSFV proliferation in ST cells with or without GCA was observed by IFA at 24, 48 and 72 hpi. Results from the three independent experiments are shown as means ± SD. *P<0.05 and **P<0.01 compared with the control group.
|
|
| S2222 |
PF-3716556PF-3716556是一种有效的，选择性的P-CAB钾离子竞争性酸抑制剂，在离子渗透和离子密集检测中，抑制猪H+，K+-ATPase活性，抑制胃酸分泌，对Na+，K+-ATPas没有作用活性，用于治疗胃食管返流疾病。 |
||
| S7460 |
BTB06584BTB06584 是IF1依赖性的，选择性的线粒体F1 Fo-ATPase抑制剂. |
Changes of mitochondrial membrane potential (ΔΨm). (A) Representative micrographs captured by confocal laser scanning microscope were evaluated for ΔΨm by staining with JC-1 at 24h post ionizing radiation. Red dimers indicated normal mitochondrial function and green monomers indicated collapse of ΔΨm with cytoplasmic fluorescence. Scale bar = 50μm. (B) Kinetics of changes of ΔΨm was showed as the ratio of red to green fluorescence in each treatment staining with JC-1 at 0.5, 6, 12, 24, 48, 72 and 96 h after X-ray radiation (IR) with or without 10μM BTB treatment. Data are expressed as means±SD of triplicate measurements. IR compared with IR+BTB, *p< 0.05, **p< 0.01, t-test. Control compared with IR+BTB, #p< 0.05, ##p< 0.01, t-test.
|
|
| S3699 |
2,3-Butanedione-2-monoxime2,3-Butanedione monoxime (BDM)是一种低亲和力的、非竞争性的skeletal muscle myosin-II抑制剂，抑制骨骼肌和心肌收缩。 |
||
| S8101 |
CB-5083CB-5083是一种有效的，选择性的，且口服具有生物活性的p97 AAA ATPase抑制剂，IC50为 11 nM。Phase 1。 |
LN229 GBM cell lysates were immunoblotted with antibodies recognizing specific focal adhesion proteins. Note the decreased levels of Cas, paxillin, and FAK tyrosine phosphorylation in cells treated with CB-5083. In addition, CB-5083 treatment leads to decreased levels of total PTP-PEST expression, but Vcp protein expression levels are not impacted.
|
|
| S3628 |
BHQBHQ是有效的、选择性的sarco-endoplasmic reticulum Ca2+-ATPase (SERCA)抑制剂。 |
||
| S8276 |
FCCPFCCP在线粒体中式一种有效的氧化磷酸化的解偶联剂，通过转运质子破坏ATP的合成。 |
The changes in 10-N-nonylacridineorange (NAO) fluorescence indicated the cardiolipin (CL) oxidation. In normal cells, NAO could interact with nonoxidized cardiolipin and produces a characteristic green fluorescence. However, after cardiolipin is oxidized, NAO cannot bind to it. F-H, The changes in MDA, GSH, and SOD levels. I and J, The cytoplasmic [Ca2+] map via confocal microscopy by Fluo-2. Fluorescence intensity of Fluo-2 was measured by excitation wavelengths of 340 nm and emission wavelengths of 500 nm. Data (F/F0) were obtained by dividing fluorescence intensity (F) by (F0) at the resting level (t = 0), which was normalized to normal groups. Data are shown as means ± SEM. *P < .05 vs normal group; #P < .05 vs PA group, @P < .05 vs PA + siRNA-NR4A1 or PA + melatonin groups
|
|
| S2623 |
Omecamtiv mecarbil (CK-1827452)Omecamtiv mecarbil (CK-1827452)是一种特异性的心肌肌球蛋白激动剂，是用于左心室收缩性心脏衰竭的临床药物。Phase 2。 |
Effects of omecamtiv mecarbil and blebbistatin on the ATPase activity of cardiomyofibrils A-C, steady-state ATPase rates for control, OM treated and BS treated CMFs at pCa 9 (A), pCa 6 (B) and pCa 4.3
(C). Values indicate means ± SEM (n = 4–8). D, dose–response curve for the effect of omecamtiv mecarbil on steady-state cardiomyofibriliar ATPase activity at pCa 4.3. Statistical significance of differences between groups were assessed by a one-way ANOVA with Turkey’s post hoc test: ∗∗P < 0.01; ∗∗∗P < 0.001.
|
-Circ-Heart-Fail-20150727.gif)
